Tag: Eflornithine

After the brand-name medication Vaniqa was discontinued in 2023, many women began seeking alternatives, and one of the most common questions is 'Is Eflora the same as Vaniqa?'. In fact, Eflora is a generic version of Vaniqa, containing the same active ingredient to treat unwanted facial hair.

Clinical studies have shown that consistent use of the active ingredient in the prescription cream Vaniqa can lead to noticeable improvements in unwanted facial hair in as little as 4 to 8 weeks. This topical treatment is specifically formulated to help women manage excessive hair growth on the face and chin.

According to the U.S. Food and Drug Administration (FDA), Vaniqa (eflornithine hydrochloride) cream is not approved for use by anyone younger than 12 years old. Understanding the specific guidelines regarding **what is the age limit for Vaniqa?** is crucial for safe and effective treatment of unwanted facial hair.

Hirsutism, or excessive male-pattern hair growth, affects between 5% and 15% of women [1.8.1]. For those prescribed Vaniqa, a key question is: **how long does it take Vaniqa to start working?** Results appear gradually, with most users seeing improvement in 4 to 8 weeks [1.2.1].

In early 2023, the manufacturer Allergan, a subsidiary of AbbVie, officially discontinued Vaniqa, the topical cream for treating excessive facial hair in women. The decision, driven primarily by financial and marketing reasons, has left many long-time users searching for answers and alternatives to this popular medication, leaving them to ask: why did they discontinue Vaniqa?.

As of 2025, eflornithine cream is not available over the counter and requires a prescription from a licensed healthcare provider. This topical medication, previously known by the brand name Vaniqa, is specifically designed to slow the growth of unwanted facial hair in women and is regulated for safety and proper use.